Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Cardias Surgery

Objective: to analyze the combined use of extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy with switching into the ECMO circuit in cardiac surgical patients over 18 years of age and to reveal predictors of a fatal outcome in this combination of auxiliary organ supp...

Full description

Bibliographic Details
Main Authors: S. V. Kolesnikov, A. S. Borisov, I. A. Kornilov, V. V. Lomivorotov
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2014-06-01
Series:Общая реаниматология
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/1403
_version_ 1826562211770793984
author S. V. Kolesnikov
A. S. Borisov
I. A. Kornilov
V. V. Lomivorotov
author_facet S. V. Kolesnikov
A. S. Borisov
I. A. Kornilov
V. V. Lomivorotov
author_sort S. V. Kolesnikov
collection DOAJ
description Objective: to analyze the combined use of extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy with switching into the ECMO circuit in cardiac surgical patients over 18 years of age and to reveal predictors of a fatal outcome in this combination of auxiliary organ support techniques. Materials and methods. The retrospective cohort study postoperatively used a combination of ECMO and continuous renal replacement therapy in 27 cardiac surgical patients aged over 18 years with severe cardiopulmonary insufficiency concurrent with acute kidney lesion. In all cases, the continuous renal replacement therapy circuit was switched into the line after an ECMO pump. The end points of the study were the duration of dialysis-dependent acute renal failure, the frequency of complications, and hospital mortality. Results. In all cases with a favorable outcome, the duration of continuous renal replacement therapy was 3 days longer than that of ECMO. There were no cases of recovery if the duration of continuous renal replacement therapy was shorter than that of ECMO and the duration of the latter was more than 10 days. The duration of sympathomimetic support (>3.5 days ) was shown to be an independent and significant predictor of death (AUC 0.99; CI 99.9%, 0.96—1.0) in the patients receiving continuous renal replacement therapy and ECMO. It was established that the number of inotrophic drugs (>2) and the highest lactate level (>1.99 mmol/l) could be used to predict hospital mortality in patients with acute kidney injury and severe cardiopulmonary insufficiency (AUC 0.85 and 0.86; sensitivity/specificity 0.83/0.67 and 0.86/0.67, respectively).Conclusion. The concurrent use of ECMO and continuous renal replacement therapy in severe cardiac surgical patients with potentially reversible cardiopulmonary insufficiency and acute kidney injury is a sound and complementary combination of auxiliary organ support techniques.
first_indexed 2024-04-10T01:27:52Z
format Article
id doaj.art-0a31e158957d4dd1b470dc883f2b9cb2
institution Directory Open Access Journal
issn 1813-9779
2411-7110
language English
last_indexed 2025-03-14T09:44:28Z
publishDate 2014-06-01
publisher Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
record_format Article
series Общая реаниматология
spelling doaj.art-0a31e158957d4dd1b470dc883f2b9cb22025-03-02T11:29:34ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102014-06-01103758410.15360/1813-9779-2014-3-75-841403Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Cardias SurgeryS. V. Kolesnikov0A. S. Borisov1I. A. Kornilov2V. V. Lomivorotov3Academician E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation, NovosibirskAcademician E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation, NovosibirskAcademician E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation, NovosibirskAcademician E. N. Meshalkin Research Institute of Circulatory Pathology, Ministry of Health of the Russian Federation, NovosibirskObjective: to analyze the combined use of extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy with switching into the ECMO circuit in cardiac surgical patients over 18 years of age and to reveal predictors of a fatal outcome in this combination of auxiliary organ support techniques. Materials and methods. The retrospective cohort study postoperatively used a combination of ECMO and continuous renal replacement therapy in 27 cardiac surgical patients aged over 18 years with severe cardiopulmonary insufficiency concurrent with acute kidney lesion. In all cases, the continuous renal replacement therapy circuit was switched into the line after an ECMO pump. The end points of the study were the duration of dialysis-dependent acute renal failure, the frequency of complications, and hospital mortality. Results. In all cases with a favorable outcome, the duration of continuous renal replacement therapy was 3 days longer than that of ECMO. There were no cases of recovery if the duration of continuous renal replacement therapy was shorter than that of ECMO and the duration of the latter was more than 10 days. The duration of sympathomimetic support (>3.5 days ) was shown to be an independent and significant predictor of death (AUC 0.99; CI 99.9%, 0.96—1.0) in the patients receiving continuous renal replacement therapy and ECMO. It was established that the number of inotrophic drugs (>2) and the highest lactate level (>1.99 mmol/l) could be used to predict hospital mortality in patients with acute kidney injury and severe cardiopulmonary insufficiency (AUC 0.85 and 0.86; sensitivity/specificity 0.83/0.67 and 0.86/0.67, respectively).Conclusion. The concurrent use of ECMO and continuous renal replacement therapy in severe cardiac surgical patients with potentially reversible cardiopulmonary insufficiency and acute kidney injury is a sound and complementary combination of auxiliary organ support techniques.https://www.reanimatology.com/rmt/article/view/1403continuous renal replacement therapyextracorporeal membrane oxygenationacute kidney injurypostoperative periodpredictorscardiac surgery.
spellingShingle S. V. Kolesnikov
A. S. Borisov
I. A. Kornilov
V. V. Lomivorotov
Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Cardias Surgery
Общая реаниматология
continuous renal replacement therapy
extracorporeal membrane oxygenation
acute kidney injury
postoperative period
predictors
cardiac surgery.
title Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Cardias Surgery
title_full Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Cardias Surgery
title_fullStr Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Cardias Surgery
title_full_unstemmed Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Cardias Surgery
title_short Continuous Renal Replacement Therapy and Extracorporeal Membrane Oxygenation in Cardias Surgery
title_sort continuous renal replacement therapy and extracorporeal membrane oxygenation in cardias surgery
topic continuous renal replacement therapy
extracorporeal membrane oxygenation
acute kidney injury
postoperative period
predictors
cardiac surgery.
url https://www.reanimatology.com/rmt/article/view/1403
work_keys_str_mv AT svkolesnikov continuousrenalreplacementtherapyandextracorporealmembraneoxygenationincardiassurgery
AT asborisov continuousrenalreplacementtherapyandextracorporealmembraneoxygenationincardiassurgery
AT iakornilov continuousrenalreplacementtherapyandextracorporealmembraneoxygenationincardiassurgery
AT vvlomivorotov continuousrenalreplacementtherapyandextracorporealmembraneoxygenationincardiassurgery